122 related articles for article (PubMed ID: 19543318)
1. Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor.
Confalonieri S; Quarto M; Goisis G; Nuciforo P; Donzelli M; Jodice G; Pelosi G; Viale G; Pece S; Di Fiore PP
Oncogene; 2009 Aug; 28(33):2959-68. PubMed ID: 19543318
[TBL] [Abstract][Full Text] [Related]
2. The inducible E3 ubiquitin ligases SIAH1 and SIAH2 perform critical roles in breast and prostate cancers.
Knauer SK; Mahendrarajah N; Roos WP; Krämer OH
Cytokine Growth Factor Rev; 2015 Aug; 26(4):405-13. PubMed ID: 26028498
[TBL] [Abstract][Full Text] [Related]
3. The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancer.
Gong X; Du D; Deng Y; Zhou Y; Sun L; Yuan S
Invest New Drugs; 2020 Apr; 38(2):515-524. PubMed ID: 32008177
[TBL] [Abstract][Full Text] [Related]
4. Semantic clustering analysis of E3-ubiquitin ligases in gastrointestinal tract defines genes ontology clusters with tissue expression patterns.
Iatsiuk V; Malinka F; Pickova M; Tureckova J; Klema J; Spoutil F; Novosadova V; Prochazka J; Sedlacek R
BMC Gastroenterol; 2022 Apr; 22(1):186. PubMed ID: 35413796
[TBL] [Abstract][Full Text] [Related]
5. A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer.
Burger AM; Gao Y; Amemiya Y; Kahn HJ; Kitching R; Yang Y; Sun P; Narod SA; Hanna WM; Seth AK
Cancer Res; 2005 Nov; 65(22):10401-12. PubMed ID: 16288031
[TBL] [Abstract][Full Text] [Related]
6. E3 ubiquitin ligases as cancer targets and biomarkers.
Sun Y
Neoplasia; 2006 Aug; 8(8):645-54. PubMed ID: 16925947
[TBL] [Abstract][Full Text] [Related]
7. WW domain containing E3 ubiquitin protein ligase 1 targets the full-length ErbB4 for ubiquitin-mediated degradation in breast cancer.
Li Y; Zhou Z; Alimandi M; Chen C
Oncogene; 2009 Aug; 28(33):2948-58. PubMed ID: 19561640
[TBL] [Abstract][Full Text] [Related]
8. Genetic and expression aberrations of E3 ubiquitin ligases in human breast cancer.
Chen C; Seth AK; Aplin AE
Mol Cancer Res; 2006 Oct; 4(10):695-707. PubMed ID: 17050664
[TBL] [Abstract][Full Text] [Related]
9. A UbcH5/ubiquitin noncovalent complex is required for processive BRCA1-directed ubiquitination.
Brzovic PS; Lissounov A; Christensen DE; Hoyt DW; Klevit RE
Mol Cell; 2006 Mar; 21(6):873-80. PubMed ID: 16543155
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous detection of distinct ubiquitin chain topologies by 19F NMR.
Shekhawat SS; Pham GH; Prabakaran J; Strieter ER
ACS Chem Biol; 2014 Oct; 9(10):2229-36. PubMed ID: 25119846
[TBL] [Abstract][Full Text] [Related]
11. Novel RING E3 ubiquitin ligases in breast cancer.
Burger A; Amemiya Y; Kitching R; Seth AK
Neoplasia; 2006 Aug; 8(8):689-95. PubMed ID: 16925951
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer.
Jansen MP; Ruigrok-Ritstier K; Dorssers LC; van Staveren IL; Look MP; Meijer-van Gelder ME; Sieuwerts AM; Helleman J; Sleijfer S; Klijn JG; Foekens JA; Berns EM
Breast Cancer Res Treat; 2009 Jul; 116(2):263-71. PubMed ID: 18629630
[TBL] [Abstract][Full Text] [Related]
13. Functional Roles of the E3 Ubiquitin Ligase UBR5 in Cancer.
Shearer RF; Iconomou M; Watts CK; Saunders DN
Mol Cancer Res; 2015 Dec; 13(12):1523-32. PubMed ID: 26464214
[TBL] [Abstract][Full Text] [Related]
14. Bacteria-host relationship: ubiquitin ligases as weapons of invasion.
Maculins T; Fiskin E; Bhogaraju S; Dikic I
Cell Res; 2016 Apr; 26(4):499-510. PubMed ID: 26964724
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
Wu JY; Vlastos AT; Pelte MF; Caligo MA; Bianco A; Krause KH; Laurent GJ; Irminger-Finger I
Int J Cancer; 2006 Mar; 118(5):1215-26. PubMed ID: 16152612
[TBL] [Abstract][Full Text] [Related]
16. Regulation of lipid metabolism by E3 ubiquitin ligases in lipid-associated metabolic diseases.
Zou Y; Zhang Y; Li M; Cao K; Song C; Zhang Z; Cai K; Geng D; Chen S; Wu Y; Zhang N; Sun G; Wang J; Zhang Y; Sun Y
Int J Biol Macromol; 2024 Apr; 265(Pt 2):130961. PubMed ID: 38508558
[TBL] [Abstract][Full Text] [Related]
17. Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis.
Sehat B; Andersson S; Girnita L; Larsson O
Cancer Res; 2008 Jul; 68(14):5669-77. PubMed ID: 18632619
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin ligases and the immune response.
Liu YC
Annu Rev Immunol; 2004; 22():81-127. PubMed ID: 15032575
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin ligases in cancer: ushers for degradation.
Newton K; Vucic D
Cancer Invest; 2007 Sep; 25(6):502-13. PubMed ID: 17882664
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assays of Mdm2 ubiquitin ligase activity and other ubiquitin-utilizing enzymes for inhibitor discovery.
Auger KR; Copeland RA; Lai Z
Methods Enzymol; 2005; 399():701-17. PubMed ID: 16338390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
